Skip to contentHit identification
Finding active hits for selected targets
To find promising hits we offer diverse screening platforms combined with chemoinformatics and medicinal chemistry supported by artificial intelligence.
- A priori selection
Selection of molecules based on publications, virtual screening and medicinal chemistry knowledge.
- Fragment Screening
The NovA-Frag library of 1000 fragments can be screened on different biophysical platforms such as NMR or native MS.
- Covalent screening
Native-MS screening using client or commercial covalent libraries.
- DNA Encoded Libraries (NovA-DEL)
Massive screening in parallel of customized general or focused libraries.
Want more information?
We are ready to support your projects
COOKIES
NovAliX place cookies on your terminal cookies from the novalix.com site, to improve your navigation experience and analyze traffic.
This page allows you to give or withdraw your consent for the use of cookies on the novalix.com site either globally (by clicking on the "Accept all" or "Reject all" button), or on a purpose-by-purpose basis (by clicking on the "Personalize my choices" button). These cookies are only placed if you give your consent.
We retain your choice for 6 months. For further information, please consult our cookie policy
Manage cookies consent
Novalix is changing the future of drug discovery with a fresh new look.
The new website is currently
under construction.